Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
4,992,318
-
Total 13F shares
-
35,661,134
-
Share change
-
-1,532,799
-
Total reported value
-
$56,343,070
-
Price per share
-
$1.58
-
Number of holders
-
69
-
Value change
-
-$6,861,654
-
Number of buys
-
33
-
Number of sells
-
28
Institutional Holders of Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) as of Q3 2019
As of 30 Sep 2019,
Mersana Therapeutics, Inc. - Common Stock, par value $0.0001 per share (MRSN) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,661,134 shares.
The largest 10 holders included
NEA Management Company, LLC, BVF INC/IL, Sarissa Capital Management LP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BOXER CAPITAL, LLC, Rock Springs Capital Management LP, JPMORGAN CHASE & CO, WELLINGTON MANAGEMENT GROUP LLP, and RHO CAPITAL PARTNERS INC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.